| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a819eda0adf22936a52362eeebb9fb4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b758fecaba243429625442aa212e8701 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-14145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-14122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-14143
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-14133 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00 |
| filingDate |
2018-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f32955b21ea1d25efbcdc2e566c3262
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19cd5d72587c484d6f75b4547908d642
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_472886e1dc9de62fff180a50ccd08113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2bcaf77b04f94816dc293586cbae6377 |
| publicationDate |
2018-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2018222503-A1 |
| titleOfInvention |
Adeno-associated virus with variant capsid and methods of use thereof |
| abstract |
The present disclosure provides recombinant adeno-associated virus (AAV) virions with altered capsid protein, where the recombinant AAV (rAAV) virions exhibit greater infectivity of a cardiac cell compared to wild-type AAV, and where the rAAV virions comprise a heterologous nucleic acid. The present disclosure provides methods of delivering a gene product to a cardiac cell in an individual. The present disclosure provides methods of generating an induced cardiomyocyte-like cell. The present disclosure provides methods of editing the genome of a cardiac cell. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11149256-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11781156-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022022624-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11015211-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021163322-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021188892-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021067598-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021202532-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023019168-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021007515-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023283649-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023172491-A1 |
| priorityDate |
2017-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |